Injection Site Reaction to Extended-Release Buprenorphine (Sublocade^®) for Opioid Use Disorder Fourteen Days after Administration.

Kansas Journal of Medicine Pub Date : 2022-08-22 eCollection Date: 2022-01-01 DOI:10.17161/kjm.vol15.17931

Elizabeth Weesner, Hosain Ghassemi, Iryna Salapenka, Jaya Sri Konakanchi, Gregory Maggio, Roopa Sethi

引用次数: 0

Abstract

302 Injection Site Reaction to ExtendedRelease Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration Elizabeth Weesner1, Hosain Ghassemi1, Iryna Salapenka, M.D.2, Jaya Sri Konakanchi, MBBS1, Gregory Maggio, D.O.2, Roopa Sethi, M.D.2 1University of Kansas School of Medicine, Kansas City, KS 2University of Kansas Health System, Kansas City, KS Department of Psychiatry and Behavioral Sciences Received April 21, 2022; Accepted for publication May 25, 2022; Published online Aug. 22, 2022 https://doi.org/10.17161/kjm.vol15.17931

Abstract Image